Identification of Microorganisms using Nucleic Acid Probes
Defines coverage status (meets or does not meet coverage criteria) for nucleic acid direct probe, amplified probe, and quantification procedures for specific microorganisms and lists applicable CPT codes. Prohibits simultaneous ordering of amplified probe and quantification for the same organism in a single encounter.
No material clinical or coverage changes noted in this update.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.